Seeking Addiction or Mental Health Treatment? (866) 593-2339
Find The Right Addiction or Mental Health Treatment Center For You

Blog

Texas mandates prescription-monitoring tools effective Sep. 2019 to fight opioid epidemic

Texas mandates prescription-monitoring tools effective Sep. 2019 to fight opioid epidemic In the United States, prescription drug monitoring programs (PDMPs) are among the most promising state-level interventions to improve current levels of prescriptions of opioids, provide data for effective clinical decisions, and protect at-risk patients. Although past studies have found varying success rates for PDMPs, these continue contributing to the overall decline in drug diversions and prescription opioid overdoses. The Texas Prescription Monitoring Program (TPMP) was created over three decades ago, but it has so far been used by limited health care providers. Effective Sep. 1, 2016, the program was taken over by the Texas State Board of Pharmacy (TSBP). This…

WellStar Health System and Pacira Pharmaceuticals to jointly develop comprehensive opioid minimization strategy

WellStar Health System and Pacira Pharmaceuticals to jointly develop comprehensive opioid minimization strategy The opioid epidemic ravaging across the United States is necessitating innovative risk management strategies to improve patient safety and reduce higher health care utilization costs. Although several players are involved in such strategies, pharmaceutical companies and health care providers have a critical role to play. Doing their bit to help control the epidemic, in January 2018, WellStar Health System (WellStar), the largest health system in Georgia, and Pacira Pharmaceuticals (Pacira), announced a partnership to develop a comprehensive strategy for minimizing opioid use and standardizing outcomes across surgical procedures. According to the strategic plan, WellStar and Pacira will work jointly in…

Mallinckrodt to pay $35 m to US government to settle opioid investigation

Dependence on prescription opioids for pain treatment and other ailments is one of the primary reasons for the opioid epidemic in the United States. Looking at the situation, federal agencies have put guidelines in place to check the distribution of pain relievers and medication containing narcotics. As part such endeavors, the Drug Enforcement Administration (DEA) initiated a probe in 2011 against Mallinckrodt Pharmaceuticals. This was because they found that between 2008 and 2012, 66 percent of all oxycodone sold in Florida came from Mallinckrodt. Now, six years later, the pharma company has agreed to pay $35 million to the American…
Copyright © 2018 - Recover Mental Health. All rights reserved. Privacy Policy - Terms